I think the important part of this is that it depressed the immune system.. Which sounds nonselective.
While an important discovery, to maintain quality of life we need to selectivly kill the bad parts leaving an immune system to save us from the common cold.
Ivan
While an important discovery, to maintain quality of life we need to selectivly kill the bad parts leaving an immune system to save us from the common cold.
Ivan
----- Original Message -----
From: "Razvan Lefter"
To: nathanfaustmantrials@yahoogroups.com
Subject: [nathanfaustmantrials] other options? Novartis Gleevec and Pfizer Sutent
Date: Mon, 17 Nov 2008 23:25:28 -0800 (PST)
Just announced this morning, does anyone have any other input on this?Kind regards, RNOVARTIS <NOVN.VX>
Two popular leukemia drugs, Gleevec and Sutent, kept lab mice from
developing type 1 diabetes and put 80 percent of diabetic mice in remission, an
international team said.
Both drugs -- Gleevec, or imatinib, made by Novartis AG <NOVN.VX> and
Sutent, or sunitinib, made by Pfizer Inc <PFE.N> -- worked by depressing the
immune systems in the mice, which maintained normal blood sugar levels even
after treatment ended .
Razvan Lefter
Mobile: + 40 752 064 000 (new!!!)
E-mail: razvan.lefter@gmail.com
\\\/ 0o http://home.goetia.net __ ! Iroseland@...
--
_______________________________________________
Get a free @hellokitty.com, @mymelody.com, or @kuririnmail.com email account
today at www.sanriotown.com, and enjoy 500MB of storage!
Check out our official blog @ http://blog.hellokitty.com